Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
Yuheng Yan, Lan Huang, Yiming Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

Metabolic interplay: tumor macrophages and regulatory T cells
Stefania Vilbois, Yingxi Xu, Ping‐Chih Ho
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 242-255
Closed Access | Times Cited: 20
Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
João Ferreira Gil, Carla Moura, Vânia Silvério, et al.
Advanced Materials (2023) Vol. 35, Iss. 35
Open Access | Times Cited: 19
Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Ion Negură, Mariana Pavel, Mihai Danciu
Cancer Treatment Reviews (2023) Vol. 120, pp. 102629-102629
Closed Access | Times Cited: 18
Lysine acetyltransferase 6A maintains CD4+ T cell response via epigenetic reprogramming of glucose metabolism in autoimmunity
Jiayao Fu, Shi-Jia Huang, Baoli Wang, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 557-574.e10
Open Access | Times Cited: 7
Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses
Huldani Huldani, Jitendra Malviya, Paul Rodrigues, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 6
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 6
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Advances and challenges of first-line immunotherapy for non-small cell lung cancer: A review
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 5
Exosomes as drug delivery systems in glioma immunotherapy
Xinqing Hao, Shiming Wang, Liang Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Unravelling immune microenvironment features underlying tumor progression in the single-cell era
Qilian Du, Qi An, Jiajun Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Integrating single-cell RNA-seq and bulk RNA-seq to explore prognostic value and immune landscapes of methionine metabolism-related signature in breast cancer
Yingchun Gao, Ziyu Feng, Hailong Zhao, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
Global Trends in Research of Amino Acid Metabolism in T Lymphocytes in Recent 15 Years: A Bibliometric Analysis
Jiaona Xu, Yinan Yu, Shijie Li, et al.
Journal of Immunology Research (2025) Vol. 2025, Iss. 1
Open Access
Fluoride-Mediated Immune Damage Through Cytokine Network Regulation of Tregs
Bingshu Liu, Siqi Zhu, Qiong Zhang, et al.
Toxics (2025) Vol. 13, Iss. 2, pp. 95-95
Open Access
Sex‐related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma
Marta Iozzo, Giuseppina Comito, Luigi Ippolito, et al.
FEBS Journal (2025)
Open Access
Metabolic Imbalance in Immune Cells in Relation to Metabolic Disorders, Cancer, and Infections
Mahmoud Singer, Rania Hamdy, Jana H. Ghonaim, et al.
(2025), pp. 187-218
Closed Access
Extracellular Vesicle‐Based Antitumor Nanomedicines
Mingfeng Li, Yanfei Liu, Fei Liu, et al.
Advanced Healthcare Materials (2025)
Closed Access
A Copper‐Manganese Based Nanocomposite Induces Cuproptosis and Potentiates Anti‐Tumor Immune Responses
Luoyingzi Xie, Jie Gong, Zhiqiang He, et al.
Small (2025)
Closed Access
Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration
Haibin Wang, Xinli Liu, Hesen Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review
VEENA V. TOM, A. De la Fuente Hernández José, Sumit Mallick, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Pediatric gliomas immunity challenges and immunotherapy advances
Eleni‐Kyriaki Vetsika, Maria A. Katsianou, Panagiotis Sarantis, et al.
Cancer Letters (2025), pp. 217640-217640
Closed Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The influence of fatty acid metabolism on T cell function in lung cancer
Jessica Petiti, Ludovica Arpinati, Alessio Menga, et al.
FEBS Journal (2025)
Closed Access
Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy
Chen‐Wei Jiang, Minglu Tang, Yun Su, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

Scroll to top